|Articles|July 20, 2023
How Can Phase I Data from the West Accelerate Drug Development in China and Japan? The Science and Practice of Ethnobridging
Author(s)PAREXEL
There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.
Trending on Applied Clinical Trials Online
1
What It Actually Means to Embed the Patient Voice in Trial Design
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
4
ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization
5